ID   RPF_MICLU               Reviewed;         223 AA.
AC   O86308;
DT   06-FEB-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 2.
DT   07-APR-2021, entry version 70.
DE   RecName: Full=Resuscitation-promoting factor Rpf;
DE            EC=3.-.-.-;
DE   Flags: Precursor;
GN   Name=rpf;
OS   Micrococcus luteus (Micrococcus lysodeikticus).
OC   Bacteria; Actinobacteria; Micrococcales; Micrococcaceae; Micrococcus.
OX   NCBI_TaxID=1270;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 42-60 AND 81-92,
RP   FUNCTION, SUBCELLULAR LOCATION, AND POSSIBLE C-TERMINAL CLEAVAGE.
RC   STRAIN=NCIMB 13267 / IAM 14879 / Fleming strain 2665;
RX   PubMed=9671779; DOI=10.1073/pnas.95.15.8916;
RA   Mukamolova G.V., Kaprelyants A.S., Young D.I., Young M., Kell D.B.;
RT   "A bacterial cytokine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:8916-8921(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], SUBCELLULAR LOCATION, INDUCTION, AND
RP   DISRUPTION PHENOTYPE.
RC   STRAIN=NCIMB 13267 / IAM 14879 / Fleming strain 2665;
RX   PubMed=12410820; DOI=10.1046/j.1365-2958.2002.03183.x;
RA   Mukamolova G.V., Turapov O.A., Kazarian K., Telkov M., Kaprelyants A.S.,
RA   Kell D.B., Young M.;
RT   "The rpf gene of Micrococcus luteus encodes an essential secreted growth
RT   factor.";
RL   Mol. Microbiol. 46:611-621(2002).
RN   [3]
RP   FUNCTION AS A MURALYTIC ENZYME, OVEREXPRESSION IN E.COLI, AND MUTAGENESIS
RP   OF ASP-48; CYS-53; GLU-54; GLN-72 AND CYS-114.
RC   STRAIN=NCIMB 13267 / IAM 14879 / Fleming strain 2665;
RX   PubMed=16359320; DOI=10.1111/j.1365-2958.2005.04930.x;
RA   Mukamolova G.V., Murzin A.G., Salina E.G., Demina G.R., Kell D.B.,
RA   Kaprelyants A.S., Young M.;
RT   "Muralytic activity of Micrococcus luteus Rpf and its relationship to
RT   physiological activity in promoting bacterial growth and resuscitation.";
RL   Mol. Microbiol. 59:84-98(2006).
RN   [4]
RP   FUNCTION AS A MURALYTIC ENZYME, AND ACTIVITY REGULATION.
RC   STRAIN=NCIMB 13267 / IAM 14879 / Fleming strain 2665;
RX   PubMed=20016836; DOI=10.1371/journal.pone.0008174;
RA   Demina G.R., Makarov V.A., Nikitushkin V.D., Ryabova O.B.,
RA   Vostroknutova G.N., Salina E.G., Shleeva M.O., Goncharenko A.V.,
RA   Kaprelyants A.S.;
RT   "Finding of the low molecular weight inhibitors of resuscitation promoting
RT   factor enzymatic and resuscitation activity.";
RL   PLoS ONE 4:E8174-E8174(2009).
RN   [5]
RP   FUNCTION AS A MURALYTIC ENZYME.
RC   STRAIN=NCIMB 13267 / IAM 14879 / Fleming strain 2665;
RX   PubMed=22864992; DOI=10.1007/s10482-012-9784-1;
RA   Nikitushkin V.D., Demina G.R., Shleeva M.O., Kaprelyants A.S.;
RT   "Peptidoglycan fragments stimulate resuscitation of 'non-culturable'
RT   mycobacteria.";
RL   Antonie Van Leeuwenhoek 103:37-46(2013).
CC   -!- FUNCTION: Factor that stimulates resuscitation of dormant cells. Has
CC       peptidoglycan (PG) hydrolytic activity. Has little to no effect on
CC       actively-growing cells. PG fragments could either directly activate the
CC       resuscitation pathway of dormant bacteria or serve as a substrate for
CC       endogenous Rpf, resulting in low molecular weight products with
CC       resuscitation activity. In pM quantities promotes the resuscitation and
CC       growth of dormant, nongrowing cells from M.luteus in addition to
CC       Mycobacterium tuberculosis, M.avium, M.bovis, M.kansaii and
CC       M.smegmatis. Hydrolyzes endogeneous cell walls, peptidoglycan
CC       preparations from Mycobacterium tuberculosis and M.smegmatis as well as
CC       an artificial lysozyme substrate 4-methylumbelliferyl-beta-D-N,N',N''-
CC       triacetylchitotrioside (MUF tri-NAG). Overexpression in E.coli (when
CC       the enzyme is targeted to the periplasm) causes cell lysis.
CC       {ECO:0000269|PubMed:16359320, ECO:0000269|PubMed:20016836,
CC       ECO:0000269|PubMed:22864992, ECO:0000269|PubMed:9671779}.
CC   -!- ACTIVITY REGULATION: Activity on the artifical substrate MUF tri-NAG is
CC       inhibited by 2-nitrophenylthiocyanates (NPT) compounds.
CC       {ECO:0000269|PubMed:20016836}.
CC   -!- SUBCELLULAR LOCATION: Secreted. Cell surface. Note=Found in culture
CC       supernatant, also accumulates on the cell surface.
CC   -!- INDUCTION: RNA is abundant in early lag phase, decreases by early mid-
CC       log phase and is undetectable by stationary phase (48 hours growth).
CC       Protein expression is slower; detectable by 5 hours, accumulating
CC       during early mid-exponential phase and then gradually disappearing by
CC       50 hours growth (late stationary phase) (at protein level).
CC       {ECO:0000269|PubMed:12410820}.
CC   -!- DOMAIN: The LysM domain is not required for resuscitation activity in
CC       vitro; in its absence the protein is active in the fM range.
CC   -!- PTM: May be subject to further C-terminal cleavage as the protein
CC       identified in gels is smaller than is expected.
CC   -!- DISRUPTION PHENOTYPE: Essential, it cannot be disrupted.
CC       {ECO:0000269|PubMed:12410820}.
CC   -!- SIMILARITY: Belongs to the transglycosylase family. Rpf subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z96935; CAB09664.2; -; Genomic_DNA.
DR   RefSeq; WP_012750944.1; NZ_NAQZ01000032.1.
DR   SMR; O86308; -.
DR   GeneID; 7985360; -.
DR   PATRIC; fig|1270.31.peg.1423; -.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   CDD; cd00118; LysM; 1.
DR   CDD; cd13925; RPF; 1.
DR   Gene3D; 3.10.350.10; -; 1.
DR   InterPro; IPR018392; LysM_dom.
DR   InterPro; IPR036779; LysM_dom_sf.
DR   InterPro; IPR023346; Lysozyme-like_dom_sf.
DR   InterPro; IPR010618; RPF.
DR   Pfam; PF01476; LysM; 1.
DR   Pfam; PF06737; Transglycosylas; 1.
DR   SMART; SM00257; LysM; 1.
DR   SUPFAM; SSF53955; SSF53955; 1.
DR   PROSITE; PS51782; LYSM; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Hydrolase; Secreted; Signal.
FT   SIGNAL          1..41
FT                   /evidence="ECO:0000269|PubMed:9671779"
FT   CHAIN           42..223
FT                   /note="Resuscitation-promoting factor Rpf"
FT                   /id="PRO_5000147745"
FT   DOMAIN          172..220
FT                   /note="LysM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01118"
FT   REGION          119..223
FT                   /note="Not required for resuscitation activity"
FT   COMPBIAS        123..171
FT                   /note="Ala-rich"
FT   MUTAGEN         48
FT                   /note="D->A: <2% MUF tri-NAG hydrolysis, 20% M.luteus cell
FT                   wall muralytic activity, loss of resuscitation activity;
FT                   when associated with K-54."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         53
FT                   /note="C->K: 6% MUF tri-NAG hydrolysis, 20% M.luteus cell
FT                   wall muralytic activity, loss of resuscitation activity;
FT                   when associated with T-114."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         54
FT                   /note="E->A: 30% MUF tri-NAG hydrolysis, 25% M.luteus cell
FT                   wall muralytic activity, significant loss of resuscitation
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         54
FT                   /note="E->K: <2% MUF tri-NAG hydrolysis, 20% M.luteus cell
FT                   wall muralytic activity, loss of resuscitation activity;
FT                   when associated with A-48."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         54
FT                   /note="E->Q: 60% MUF tri-NAG hydrolysis, 25% M.luteus cell
FT                   wall muralytic activity, about 2% resuscitation activity."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         72
FT                   /note="Q->K: Little effect on function."
FT                   /evidence="ECO:0000269|PubMed:16359320"
FT   MUTAGEN         114
FT                   /note="C->T: 6% MUF tri-NAG hydrolysis, 20% M.luteus cell
FT                   wall muralytic activity, loss of resuscitation activity;
FT                   when associated with K-53."
FT                   /evidence="ECO:0000269|PubMed:16359320"
SQ   SEQUENCE   223 AA;  23192 MW;  505C564132210705 CRC64;
     MDTMTLFTTS ATRSRRATAS IVAGMTLAGA AAVGFSAPAQ AATVDTWDRL AECESNGTWD
     INTGNGFYGG VQFTLSSWQA VGGEGYPHQA SKAEQIKRAE ILQDLQGWGA WPLCSQKLGL
     TQADADAGDV DATEAAPVAV ERTATVQRQS AADEAAAEQA AAAEQAVVAE AETIVVKSGD
     SLWTLANEYE VEGGWTALYE ANKGAVSDAA VIYVGQELVL PQA
//
